Press release
High Blood Pressure/Hypertension Drugs Monitoring Device Market Size, Share, Trends, Growth and Forecast 2025
The high blood pressure/hypertension drugs monitoring device market is expected to grow significantly during the forecast period (2018-2023). High blood pressure or hypertension occurs when there is resistance in the blood flow due to narrow arteries. High blood pressure is a major health problem that has complications which includes heart diseases, kidney diseases, hardening of the arteries, eye damages and strokes. The hypertension market is growing significantly due to various factors such as increasing incidences of hypertension and government funded programs and initiatives. Rising lifestyle related health issues and obesity among people due to consumption of fast foods and unhealthy food also drive the growth of the market. Increasing investment in the field of research and development helps for the growth of the market. Changing and hectic lifestyle of people due to consumption of alcohol and smoking, technological advancement in blood pressure monitoring devices, and increasing healthcare expenditure creates future opportunity for the expansion of the market. Although factors such as inadequate healthcare infrastructure in many underdeveloped and developing countries hinders the hypertension drugs monitoring device market growth.Get Sample Copy of High Blood Pressure/Hypertension Drugs Monitoring Device Market at: https://www.omrglobal.com/request-sample/hypertension-drugs-monitoring-device-market
The key players contributing to the global market comprise of Eli Lilly and Company, Pfizer Inc., Bayer AG, Novartis International AG, Merck & Co. Inc., Sanofi S.A., Reata pharmaceuticals Inc., Lung Biotechnology PBC, and others.
The market can be segmented on the basis of drugs, monitoring devices and end users. On the basis of drugs, the market is subdivided as pulmonary hypertension drugs and systemic hypertension drugs. According to the monitoring devices, the market is diversified as aneroid sphygmomanometers; mercury sphygmomanometer, ambulatory BP monitors and digital devices. And as per end users, the market is sub-segmented as hospitals and clinics and homecare.
For More Information, get A full report of High Blood Pressure/Hypertension Drugs Monitoring Device Market is available at: https://www.omrglobal.com/industry-reports/hypertension-drugs-monitoring-device-market
Geographically, the market is divided into North America, Europe, Asia Pacific and Rest of the world. North America covers the largest market share due to developed technology and adequate healthcare infrastructure. Asia Pacific is considered as the fastest growing region. One of the market players, Pfizer Inc., in April 2017, collaborated with the international nonprofit organization Population Services International (PSI) for expanding access to life-saving hypertension medicines and treatment services in Vietnam and Myanmar.
Market Segmentation
By Drugs
o Pulmonary Hypertension Drugs
o Systemic Hypertension Drugs
By Monitoring Devices
o Aneroid Sphygmomanometers
o Mercury Sphygmomanometer
o Digital Devices
o Ambulatory Bp Monitors
By End User
o Hospitals and Clinics
o Homecare
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/hypertension-drugs-monitoring-device-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release High Blood Pressure/Hypertension Drugs Monitoring Device Market Size, Share, Trends, Growth and Forecast 2025 here
News-ID: 1968172 • Views: …
More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…

Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…